ReviewSe pu = Chinese journal of chromatography2026
[Advances in application of cell imprinting technology in biomedical field].
Review in Se pu = Chinese journal of chromatography, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [Tripeptide polymer-based cell-imprinted hydrogels for high-efficiency circulating tumor cell capture].Se pu = Chinese journal of chromatography · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cell imprinting technology, as a key technique in the field of cell-specific recognition, has become an important cornerstone of modern biomedical research. It relies on its precise recognition capability for biomarkers such as cell surface antigens and receptors. This technology is not only widely applied in basic fields, including disease marker detection and research on cell function and behavioral mechanisms, but also plays a crucial role in frontier applications like rare cell isolation and targeted drug development. It continuously promotes the innovative development of life science research. Although significant progress has been made in this technology, it still faces several urgent challenges. These specifically include optimization of the imprinting process (to enhance anti-interference ability and fidelity) and development of new methods adapted to complex biological environments. In response to these issues, researchers have achieved breakthrough progress in multiple fields through innovative material design and process optimization recently. First, in rare cell capture, this technology has significantly improved the separation efficiency of key rare cells in complex samples, providing an efficient solution for early cancer diagnosis and blood disease research. Second, in the field of cell culture, its unique imprinted surface can precisely regulate the expression of cell adhesion proteins to optimize the in vitro culture microenvironment. Finally, in biosensing, sensors developed based on this technology have demonstrated excellent sensitivity and specificity, opening up new avenues for disease monitoring. This paper systematically reviews the research status and development trends of cell imprinting technology, deeply analyzes its technical bottlenecks and breakthrough directions. The aim is to provide a comprehensive theoretical reference for related research and further promote the innovative application and leapfrog development of this technology in the biomedical field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.